IGAM
MRNA icon

iA Global Asset Management’s Moderna MRNA Stock Holding History

iA Global Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-39,184
Closed -$2.62M – 485
2024
Q3 		$2.62M Buy
39,184
+1,536
+4% +$141K 0.05% 229
2024
Q2 		$4.47M Buy
37,648
+1,748
+5% +$221K 0.09% 159
2024
Q1 		$3.83M Buy
35,900
+1,609
+5% +$162K 0.08% 179
2023
Q4 		$3.41M Buy
34,291
+2,568
+8% +$216K 0.08% 184
2023
Q3 		$3.28M Buy
31,723
+8,213
+35% +$916K 0.09% 179
2023
Q2 		$2.86M Buy
+23,510
New +$3.14M 0.08% 197

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

iA Global Asset Management's MRNA Position: Q4 2024 in Review

iA Global Asset Management sold out of Moderna (MRNA) in Q4 2024, closing a stake of 39,184 shares — an estimated $2.62M sold.

iA Global Asset Management first reported a position in MRNA in Q2 2023 and held it in 6 quarters. The position peaked at $4.47M in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • iA Global Asset Management reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • iA Global Asset Management sold 39,184 Moderna shares in Q4 2024, an estimated $2.62M.
  • iA Global Asset Management first reported a position in Moderna in Q2 2023 and held it in 6 quarters.
  • iA Global Asset Management's Moderna position peaked at $4.47M in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on iA Global Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.